The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Comparative study of the efficacy of breast cancer neoadjuvant chemotherapy (NAC) in patients (pts) with BRCA1/2 mutation vs sporadic cancer cases versus pts with a family history but no BRCA1/2 mutation.
Francois P. Duhoux
No relevant relationships to disclose
Yann De Rycke
No relevant relationships to disclose
Marie-Christine Falcou
No relevant relationships to disclose
Francois-Clement Bidard
No relevant relationships to disclose
Youlia M. Kirova
No relevant relationships to disclose
Alexia Savignoni
No relevant relationships to disclose
Severine Alran
No relevant relationships to disclose
Jean-Yves Pierga
No relevant relationships to disclose
Bernard Asselain
No relevant relationships to disclose
Dominique Stoppa-Lyonnet
No relevant relationships to disclose
Anne De La Rochefordiere
No relevant relationships to disclose